表紙
市場調查報告書
商品編碼
971935

神經介入設備的全球市場:按類型,技術,最終用戶和地區劃分的市場規模調查和前景(2020-2027)

Global Neurointerventional Devices Market Size study, by Type; Technique; End User and Regional Forecasts 2020-2027

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

2019年,神經介入設備的市場規模將約為25億美元,預計在2020-2027年的預測期間將以超過8%的健康增長率增長。神經介入放射學或神經血管外科手術是一種相對較新的醫學專業,它使用微創血管內技術來治療血管性腦病。發生在椎管或腦動脈的疾病是神經乾預。由於神經介入具有減少侵入性的有益功能,因此它在神經病學家中廣受歡迎。該市場是患者,正在開發和推廣產品,有吸引力的醫療費用報銷,新興市場中醫療系統的增長以及消費者對有效神經血管產品的需求的廣泛目標受眾。由增長帶動。

全球市場的領先公司正在採取各種策略來獲得競爭優勢,包括產品發佈,併購,合夥和協議,投資和融資。例如,在2016年7月,為建立OLIF(單向外側椎間融合器)模型,Medtronic plc推出了Pivox斜向外側脊柱椎體,其中側板用於OLIF25,而Divergence-L前/斜向腰椎融合系統用於OLIF51。引入系統(Pivox對角外側脊柱系統)。對於前柱支撐,OLIF平台是一種用於將電極插入椎間隙的微創脊柱融合手術。然而,嚴格的法規和熟練的神經外科醫生的短缺將阻礙市場在2020-2027年預測期內的增長。

本報告調查了神經乾預設備的全球市場,提供了市場概況,分析了市場增長和障礙,市場機會以及按類型,技術,最終用戶和地區劃分的市場規模趨勢和預測。它提供系統信息,例如競爭狀況和主要公司的概況。

目錄

第1章執行摘要

第2章市場定義和範圍

第3章市場動態

  • 市場影響分析(2018-2027)

第4章行業分析

  • 波特的五力模型
  • PEST分析
  • 投資採用模型
  • 分析師的建議和結論

第5章按類型

  • 市場概況
  • 績效:通過潛力分析
  • 估計和預測:2017年至2027年(10億美元)
  • 細分分析
    • 神經血管血栓去除裝置
    • 神經血管支架
    • 刺繡保護裝置
    • 囊內裝置
    • 栓塞線圈
    • 分流器
    • 液體栓塞
    • 氣球
    • 支架檢索器

第6章按技術

  • 市場概況
  • 績效:通過潛力分析
  • 估計和預測:2017年至2027年(10億美元)
  • 細分分析
    • 神經血栓形成
    • 支架放置
    • 線圈栓塞
    • 腦血管造影
    • 流量中斷

第7章最終用戶

  • 市場概況
  • 績效:通過潛力分析
  • 估計和預測:2017年至2027年(10億美元)
  • 細分分析
    • 醫院
    • 門診手術中心

第8章(按地區)

  • 區域市場概況
  • 北美
    • 美國
    • 加拿大
  • 歐洲快照
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區快照
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲快照
    • 巴西
    • 墨西哥
  • 其他地區

第9章競爭信息

  • 頂級市場策略
  • 公司簡介
    • Medtronic
    • Stryker
    • iVascular S.L.U.
    • Terumo Corporation
    • Boston Scientific Corporation
    • Merit Medical Systems
    • Penumbra, Inc.
    • Rapid Medical
    • MicroPort Scientific Corporation
    • InspireMD, Inc.

第10章調查流程

目錄

Title:
Global Neurointerventional Devices Market Size study, by Type (Neurovascular Thrombectomy Devices, Neurovascular Stents, Embolic Protection Devices, Intrasaccular Devices, Embolic Coils, Flow Diverters, Liquid Embolics, Balloons, and Stent Retrievers); Technique (Neurothrombectomy, Stenting, Coiling Procedure, Cerebral Angiography, Flow Disruption); End User (Hospitals, Ambulatory Surgical Centers) and Regional Forecasts 2020-2027.

Global Neurointerventional Devices Market is valued approximately USD 2.5 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 8% over the forecast period 2020-2027.Neurointerventional radiology or neurovascular surgery is a relatively new medical specialty using minimally invasive endovascular techniques to treat vascular brain diseases. The treatment of disorders that occur inside the spinal cavity or the arteries of the brain is Neurointerventional. Neurointerventional is gaining great popularity among neuro-specialists due to its advantageous function of decreased invasiveness. The market is driven by wide target demographic of patients, continuing product creation and promotion, attractive medical reimbursements, healthcare system growth across developing markets, increasing consumer demand for successful neurovascular products. The key players of global Neurointerventional devices market have adopted various strategies to gain competitive advantage including product launch, mergers and acquisition, partnerships and agreements, investment, funding and others. For instance, In July 2016, to build the OLIF (Oblique Lateral Interbody Fusion) Model, Medtronic plc unveiled its Pivox Oblique Lateral Spinal System with Lateral Plate for OLIF25 and Divergence-L Anterior / Oblique Lumbar Fusion System for OLIF51. For anterior column support, the OLIF platform is a minimally invasive spinal fusion process used to insert an electrode in the disc space. However, stringent regulations, dearth of skilled neurosurgeons impedes the growth of the market over the forecast period of 2020-2027.

The regional analysis of global Neurointerventional Devices Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of healthcare system growth across developing markets, increasing consumer demand for successful neurovascular products. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as wide target demographic of patients, continuing product creation and promotion, attractive medical reimbursements would create lucrative growth prospects for the Neurointerventional Devices Market across Asia-Pacific region.

Major market player included in this report are:

  • Medtronic
  • Stryker
  • iVascular S.L.U.
  • Terumo Corporation
  • Boston Scientific Corporation
  • Merit Medical Systems
  • Penumbra, Inc.
  • Rapid Medical
  • MicroPort Scientific Corporation
  • InspireMD, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Neurovascular Thrombectomy Devices
  • Neurovascular Stents
  • Embolic Protection Devices
  • Intrasaccular Devices
  • Embolic Coils
  • Flow Diverters
  • Liquid Embolics
  • Balloons
  • Stent Retrievers

By Technique:

  • Neurothrombectomy
  • Stenting
  • Coiling Procedure
  • Cerebral Angiography
  • Flow Disruption

By End user:

  • Hospitals
  • Ambulatory Surgical Centers

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2017, 2018
  • Base year - 2019
  • Forecast period - 2020 to 2027

Target Audience of the Global Neurointerventional Devices Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Neurointerventional Devices Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Neurointerventional Devices Market, by Type, 2018-2027 (USD Billion)
    • 1.2.3. Neurointerventional Devices Market, by Technique, 2018-2027 (USD Billion)
    • 1.2.4. Neurointerventional Devices Market, by End user, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Neurointerventional Devices Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Neurointerventional Devices Market Dynamics

  • 3.1. Neurointerventional Devices Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Neurointerventional Devices Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Neurointerventional Devices Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Neurointerventional Devices Market by Type, Performance - Potential Analysis
  • 5.3. Global Neurointerventional Devices Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
  • 5.4. Neurointerventional Devices Market, Sub Segment Analysis
    • 5.4.1. Neurovascular Thrombectomy Devices
    • 5.4.2. Neurovascular Stents
    • 5.4.3. Embolic Protection Devices
    • 5.4.4. Intrasaccular Devices
    • 5.4.5. Embolic Coils
    • 5.4.6. Flow Diverters
    • 5.4.7. Liquid Embolics
    • 5.4.8. Balloons
    • 5.4.9. Stent Retrievers

Chapter 6. Global Neurointerventional Devices Market, by Technique

  • 6.1. Market Snapshot
  • 6.2. Global Neurointerventional Devices Market by Technique, Performance - Potential Analysis
  • 6.3. Global Neurointerventional Devices Market Estimates & Forecasts by Technique 2017-2027 (USD Billion)
  • 6.4. Neurointerventional Devices Market, Sub Segment Analysis
    • 6.4.1. Neurothrombectomy
    • 6.4.2. Stenting
    • 6.4.3. Coiling Procedure
    • 6.4.4. Cerebral Angiography
    • 6.4.5. Flow Disruption

Chapter 7. Global Neurointerventional Devices Market, by End user

  • 7.1. Market Snapshot
  • 7.2. Global Neurointerventional Devices Market by End user, Performance - Potential Analysis
  • 7.3. Global Neurointerventional Devices Market Estimates & Forecasts by End user 2017-2027 (USD Billion)
  • 7.4. Neurointerventional Devices Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Ambulatory Surgical Centers

Chapter 8. Global Neurointerventional Devices Market, Regional Analysis

  • 8.1. Neurointerventional Devices Market, Regional Market Snapshot
  • 8.2. North America Neurointerventional Devices Market
    • 8.2.1. U.S. Neurointerventional Devices Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2017-2027
      • 8.2.1.2. Technique breakdown estimates & forecasts, 2017-2027
      • 8.2.1.3. End user breakdown estimates & forecasts, 2017-2027
    • 8.2.2. Canada Neurointerventional Devices Market
  • 8.3. Europe Neurointerventional Devices Market Snapshot
    • 8.3.1. U.K. Neurointerventional Devices Market
    • 8.3.2. Germany Neurointerventional Devices Market
    • 8.3.3. France Neurointerventional Devices Market
    • 8.3.4. Spain Neurointerventional Devices Market
    • 8.3.5. Italy Neurointerventional Devices Market
    • 8.3.6. Rest of Europe Neurointerventional Devices Market
  • 8.4. Asia-Pacific Neurointerventional Devices Market Snapshot
    • 8.4.1. China Neurointerventional Devices Market
    • 8.4.2. India Neurointerventional Devices Market
    • 8.4.3. Japan Neurointerventional Devices Market
    • 8.4.4. Australia Neurointerventional Devices Market
    • 8.4.5. South Korea Neurointerventional Devices Market
    • 8.4.6. Rest of Asia Pacific Neurointerventional Devices Market
  • 8.5. Latin America Neurointerventional Devices Market Snapshot
    • 8.5.1. Brazil Neurointerventional Devices Market
    • 8.5.2. Mexico Neurointerventional Devices Market
  • 8.6. Rest of The World Neurointerventional Devices Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Medtronic
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Stryker
    • 9.2.3. iVascular S.L.U.
    • 9.2.4. Terumo Corporation
    • 9.2.5. Boston Scientific Corporation
    • 9.2.6. Merit Medical Systems
    • 9.2.7. Penumbra, Inc.
    • 9.2.8. Rapid Medical
    • 9.2.9. MicroPort Scientific Corporation
    • 9.2.10. InspireMD, Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, REPORT SCOPE
  • TABLE 2. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
  • TABLE 3. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY TYPE 2017-2027 (USD BILLION)
  • TABLE 4. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY TECHNIQUE 2017-2027 (USD BILLION)
  • TABLE 5. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY END USER, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 6. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 7. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 8. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 9. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 10. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 11. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 12. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 13. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 14. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 15. U.S. NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 16. U.S. NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 17. U.S. NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 18. CANADA NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 19. CANADA NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 20. CANADA NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 21. UK NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 22. UK NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 23. UK NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 24. GERMANY NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 25. GERMANY NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 26. GERMANY NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 27. ROE NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 28. ROE NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 29. ROE NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 30. CHINA NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 31. CHINA NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 32. CHINA NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 33. INDIA NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 34. INDIA NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 35. INDIA NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 36. JAPAN NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 37. JAPAN NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 38. JAPAN NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 39. ROAPAC NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 40. ROAPAC NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 41. ROAPAC NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 42. BRAZIL NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 43. BRAZIL NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 44. BRAZIL NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 45. MEXICO NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 46. MEXICO NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 47. MEXICO NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 48. ROLA NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 49. ROLA NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 50. ROLA NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 51. ROW NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 52. ROW NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 53. ROW NEUROINTERVENTIONAL DEVICES MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 54. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL NEUROINTERVENTIONAL DEVICES MARKET
  • TABLE 55. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL NEUROINTERVENTIONAL DEVICES MARKET
  • TABLE 56. YEARS CONSIDERED FOR THE STUDY
  • TABLE 57. EXCHANGE RATES CONSIDERED

LIST OF FIGURES

  • FIG 1. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, KEY TRENDS 2019
  • FIG 5. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, GROWTH PROSPECTS 2020-2027
  • FIG 6. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 10. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 11. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 12. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 13. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 14. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, REGIONAL SNAPSHOT 2017 & 2027
  • FIG 15. NORTH AMERICA NEUROINTERVENTIONAL DEVICES MARKET 2017 & 2027 (USD BILLION)
  • FIG 16. EUROPE NEUROINTERVENTIONAL DEVICES MARKET 2017 & 2027 (USD BILLION)
  • FIG 17. ASIA PACIFIC NEUROINTERVENTIONAL DEVICES MARKET 2017 & 2027 (USD BILLION)
  • FIG 18. LATIN AMERICA NEUROINTERVENTIONAL DEVICES MARKET 2017 & 2027 (USD BILLION)
  • FIG 19. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, COMPANY MARKET SHARE ANALYSIS (2019)